Blocking EYA3 Enzyme May Prevent Vascular Remodeling Seen in PAH, Study Suggests
An enzyme involved in DNA damage processes, called EYA3, contributes to structural changes in lung blood vessels and to the progression of pulmonary hypertension (PH), according to a study in patient-derived cells and in rats. These findings also suggest that blocking EYA3 could be an effective treatment for people…